Research
Molecular
Artificial intelligence (AI) is a pivotal tool in drug discovery for developing next-generation anti-obesity therapeutics.
Practitioners should consider integrating AI tools in their drug discovery processes for obesity treatments.
StrongSupportsmedium confidence
Artificial intelligence (AI) is emerging as a pivotal tool in drug discovery, expediting the identification of novel drug candidates and optimizing treatment strategies.
Why this rating
The abstract discusses a review of AI's role in drug discovery, indicating a comprehensive analysis.
Source
Artificial intelligence in anti-obesity drug discovery: unlocking next-generation therapeutics
Amit Gangwal et al. · Drug Discovery Today · 2025
DOI 10.1016/j.drudis.2025.104333
reviewCited 8×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Molecular
- QRISK decreased markedly after weight loss from 18.9 ± 2.2% to 11.2 ± 1.6%, p < 0.0001.Strong
- Normalization of 10-year cardiovascular risk and heart age is possible after substantial dietary weight loss and remission of T2DM.Strong
- The Low-Fat Plus diet resulted in a greater reduction in total cholesterol compared to the Low-Fat diet, with changes of -0.46 mmol/L (-17.6 mg/dL) versus -0.24 mmol/L (-9.2 mg/dL) respectively (P = 0.01).Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →